Studies performed in mouse models of EAE (33) and atherosclerosis (36) have further confirmed that PD-L1+ Bregs and MZB cells could inhibit the development of Tfh cells and Tfh cell-mediated proatherogenic response, eventually abrogating the acceleration of diseases. This evidence concerns the gene CD274 and atherosclerosis.